22nd February, 2021

DigitalHealth.London Accelerator alumnus, Vinehealth, has secured a £1million Biomedical Catalyst grant to deliver their innovative cancer companion app to four NHS trusts within a randomised controlled trial. This will generate robust evidence of the platform’s clinical and cost effectiveness in improving patient self-management and data collection.

Since the company’s launch in 2019, Vinehealth has had many achievements. One of the most notable was being announced as the highest rated cancer app in the world by leading organisation ORCHA, where Vinehealth scored 93%, over 10% higher than any other cancer tool. In 2020, Vinehealth was a winner of the NHSx Techforce19 grant, partnering with The Royal Marsden, a world-leading cancer centre to fulfil the scope of supporting the mental health and well-being of cancer patients during the COVID-19 pandemic. Vinehealth works with the UK’s leading charities, such as CRUK, Macmillan and Bowel Cancer UK, whose invaluable supportive content features in the app. 

“Vinehealth have been extensively supported by the UK healthcare system by NHSx and the Academic Health Science Networks, including DigitalHealth.London” Vinehealth’s CEO, Rayna Patel said.

The Vinehealth app enables cancer patients to better self-manage their medications, side-effects, symptoms and lifestyles, seamlessly integrating with smartphones and wearables. Patients can regularly enter outcome data to support clinical decision-making, inform service delivery and drive clinical research.

Rayna Patel continued: “Providing remote patient support and enabling clinicians to understand how their patients are doing remotely is crucial in a post-pandemic world. Vinehealth is at the forefront of this shift and we are delighted to be recognised in the way by Innovate UK”. Innovate UK received 373 submitted applications, approximately triple the usual number, and were able to fund 18 projects. The lowest score of the funded project was 60%, with Vinehealth scoring a phenomenal 86.8%” – a fantastic achievement for the Vinehealth team. 

This is an exciting and crucial step towards changing the scope of care and outcomes for cancer patients in the UK, using remote digital care combining behavioural science and AI to improve cancer patient quality of life, and collect the PRO data that pharmaceutical companies need to deliver patient-centric treatments.

For more information about Vinehealth click here.


Vinehealth is an alumnus of the DigitalHealth.London Accelerator programme.

The DigitalHealth.London Accelerator is a collaborative programme funded by London’s three Academic Health Science Networks – UCL Partners, Imperial College Health Partners, and the Health Innovation Network, MedCity, CW+ and receives match funding from the European Regional Development Fund.